Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Po-Sheng Yang"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Introduction The prognostic capability of targeted sequencing of primary tumors in patients with estrogen receptor‐positive, human epidermal growth factor receptor‐2‐negative early‐stage invasive breast cancer (EBC) in a real‐world
Externí odkaz:
https://doaj.org/article/75fbb9c728d54bce854a4f9638434bf0
Autor:
Chun Chen, Yin-Chen Hsu, Kuang-Wei Chou, Kuo-Song Chang, Ya-Hui Hsu, Wei-Huai Chiu, Chun-Wei Lee, Po-Sheng Yang, Wen-Han Chang, Yao-Kuang Huang, Pang-Yen Chen, Chien-Wei Chen, Yu-Jang Su
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e30581- (2024)
This study examines the predictive value of elevated N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels for mortality among patients with end-stage renal disease (ESRD). Data from 768 ESRD patients, excluding those with cancer or lost follo
Externí odkaz:
https://doaj.org/article/d3a34a947d01459b82e6ec1ce559cecd
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Objectives: To evaluate the effects of Reishimmune-S, a fungal immunomodulatory peptide, on the quality of life (QoL) and natural killer (NK) cell subpopulations in patients receiving adjuvant endocrine therapy (ET) for breast cancer (BC). Methods: P
Externí odkaz:
https://doaj.org/article/4098465ac0c64d1ab7f6dd60f479a2c0
Autor:
Chi-Chan Lee, Horng-Woei Yang, Chih-Ju Liu, Fang Lee, Wen-Ching Ko, Yuan-Ching Chang, Po-Sheng Yang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract There is little research about the stress, quality of life (QOL) and gut microbiota in newly diagnosed breast cancer patients. In this study addressing the dearth of research on stress, quality of life (QOL), and gut microbiota in newly diag
Externí odkaz:
https://doaj.org/article/dcee2f9a541e4fd9abfb02af415de173
Autor:
Teng-Kai Yang, Ya-Fang Yu, Chiao-Ling Tsai, Hsing-Ju Li, Po-Sheng Yang, Kai-Wen Huang, Jason Chia-Hsien Cheng
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Cancer therapy has evolved from non-specific cytotoxic agents to a selective, mechanism-based approach that includes targeted agents and immunotherapy. Although the response to targeted therapies for unresectable hepatocellular ca
Externí odkaz:
https://doaj.org/article/4ec92134d42e4c90971f051db3f968a5
Autor:
Po-Sheng Yang, Ying-Ting Chao, Chun-Fan Lung, Chien-Liang Liu, Yuan-Ching Chang, Ker-Chau Li, Yi-Chiung Hsu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Breast cancer is the most common invasive cancer in women worldwide. Next-generation sequencing (NGS) provides a high-resolution profile of cancer genome. Our study ultimately gives the insight for genetic screening to identify the minority of patien
Externí odkaz:
https://doaj.org/article/0688d236bf5e42078219f324f0beef24
Autor:
Chuan-Hsun Chang, Po-Sheng Yang, Chia-Ming Hsieh, Ting-Hao Chen, Skye Hung-Chun Cheng, Cheng-En Yang, Chiun-Sheng Huang
Publikováno v:
Diagnostics, Vol 12, Iss 11, p 2850 (2022)
The applicability of the Oncotype DX® (Genomic Health, Inc., Redwood City, CA, USA) recurrence score (RS) in Asian populations is unclear. A 23-gene classifier, RecurIndex® (Amwise Diagnostics, Pte. Ltd., Singapore), has been developed based on the
Externí odkaz:
https://doaj.org/article/df61df0a3ac84707a5135a119878ec91
Publikováno v:
Journal of Cancer Research and Practice, Vol 4, Iss 3, Pp 95-99 (2017)
Background: The tumor-promoting or tumor-suppressing role of tumor-associated lymphocytes remains a subject of debate. We examined thyroid cancer data from The Cancer Genome Atlas in an attempt to define the relationship between lymphocyte infiltrate
Externí odkaz:
https://doaj.org/article/8b3bd7547c154f10bd862bca6b861f61
Publikováno v:
Journal of Cancer Research and Practice, Vol 2, Iss 4, Pp 325-329 (2015)
Lymphoepithelioma-like cholangiocarcinoma (LELCC) is a rare variant of intrahepatic cholangiocarcinoma. We herein have reported an unusual case of LELCC in a 71-year-old Taiwanese women with cirrhotic liver disease and chronic hepatitis C. The patien
Externí odkaz:
https://doaj.org/article/0ea2ebeba4834747b16fa1db02e35db8
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 12 (2018)
The clinical benefit of adding platinum to adjuvant chemotherapy for patients with triple-negative breast cancer (TNBC) has not been well investigated, although it was associated an improved response rate in neoadjuvant setting. We retrospectively an
Externí odkaz:
https://doaj.org/article/26e55da96de24d10ac7246d7a72810c4